Axsome Therapeutics, Inc. (AXSM)
Market Closed
3 Jun, 20:00
$
233. 47
+11.31
+5.09%
$
11.43B Market Cap
- P/E Ratio
- Div Yield
658,529 Volume
-4.27 Eps
$ 222.16
Previous Close 
Want to track AXSM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Axsome Therapeutics, Inc. (AXSM) Statistics
Valuation metrics
Market Cap 11.43B
Enterprise value 9.25B
Trailing P/E (ttm) -50.64
Forward P/E 29.89
PEG ratio 0.8
Price/Sales (ttm) 14.66
Price/Book (mrq) 105.46
Enterprise Value/Revenue 14.49
Enterprise Value/EBITDA -57.78
Overview
Shares outstanding 50.88M
Float 43.24M
Shares short 2.83M
% Held by insiders 0.15%
% Held by institutions 0.76%
Average volume (10 days) 639.44K
Average volume (90 days) 603.49K
Price summary
52-Week low 96.09
52-Week high 238.56
Beta 0.47
50-Day moving average 170.63
200-Day moving average 144.34
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.29%
Operating margin -0.18%
Operational effectiveness
Return on assets -0.17%
Return on equity -2.52%
Income Statement
Revenue (ttm) 638.5M
Revenue per share (ttm) 12.84
Quarterly revenue growth (yoy) 0.65%
Gross profit (ttm) 591.02M
EBITDA -160.17M
Net income to common (ttm) -183.17M
Diluted EPS (ttm) -3.68
Quarterly earnings growth (yoy) 0.65%
Balance Sheet
Total cash (mrq) 322.93M
Total cash per share (mrq) 6.31
Total debt (mrq) 218.11M
Total Debt/Equity (mrq) 247.03
Current ratio (mrq) 1.55%
Book value per share (mrq) 1.74
Cash Flow
Cash flow statement -93.41M
Levered free cash flow (LFCF) -29.42M
